(3 intermediate revisions by one other user not shown) | |||
Line 34: | Line 34: | ||
<div class="col-container"> | <div class="col-container"> | ||
<div class="col"> | <div class="col"> | ||
− | + | ||
<img src="https://static.igem.org/mediawiki/2018/a/a0/T--Imperial_College--arbor.png" width="22%"> | <img src="https://static.igem.org/mediawiki/2018/a/a0/T--Imperial_College--arbor.png" width="22%"> | ||
</br> | </br> | ||
Line 42: | Line 42: | ||
<div class="col"> | <div class="col"> | ||
− | + | ||
<img src="https://static.igem.org/mediawiki/2018/e/ee/T--Imperial_College--BMG.png" width="22%"> | <img src="https://static.igem.org/mediawiki/2018/e/ee/T--Imperial_College--BMG.png" width="22%"> | ||
</br> | </br> | ||
Line 51: | Line 51: | ||
<div class="col-container"> | <div class="col-container"> | ||
+ | <div class="col"> | ||
+ | |||
+ | |||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2018/8/81/T--Imperial_College--biolegiologo.png"width="20%"> | ||
+ | </br> | ||
+ | <p1>Biolegio was founded in 1996 in Nijmegen, the Netherlands. The first production facility was located on the campus of the Radboud University in Nijmegen. After several years of growth the company needed more space to keep up with demands and moved to a new building. | ||
+ | This new building, still located in Nijmegen, offered the space we needed for expanding our endeavors. The product range has expanded from custom made oligonucleotides to highly modified oligonucleotides, fitted with every commercially available modification. Making them suitable for a wide range of applications including (Next Generation) Sequencing, PCR, Real-Time PCR, SNP detection, genotyping, gene expression and mutation detection. | ||
+ | Biolegio now has over 19 years of experience with the synthesis of oligos and has satisfied customers located all over the world. They use our products on a daily basis and benefit from our specialist knowledge within the field.</p1> | ||
+ | |||
+ | |||
+ | </div> | ||
<div class="col"> | <div class="col"> | ||
− | + | ||
<img src="https://static.igem.org/mediawiki/2018/1/1a/T--Imperial_College--clarafi.png"width="14%"> | <img src="https://static.igem.org/mediawiki/2018/1/1a/T--Imperial_College--clarafi.png"width="14%"> | ||
</br> | </br> | ||
Line 58: | Line 70: | ||
</div> | </div> | ||
− | + | </div> | |
+ | <div class="col-container"> | ||
<div class="col"> | <div class="col"> | ||
− | + | ||
<img src="https://static.igem.org/mediawiki/2018/d/d7/T--Imperial_College--eppendorf.png"width="20%"> | <img src="https://static.igem.org/mediawiki/2018/d/d7/T--Imperial_College--eppendorf.png"width="20%"> | ||
</br> | </br> | ||
Line 67: | Line 80: | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
<div class="col"> | <div class="col"> | ||
− | + | ||
</br> | </br> | ||
<img src="https://static.igem.org/mediawiki/2018/2/20/T--Imperial_College--IDT.png"width="24%"> | <img src="https://static.igem.org/mediawiki/2018/2/20/T--Imperial_College--IDT.png"width="24%"> | ||
Line 79: | Line 89: | ||
<p1> Integrated DNA Technologies, Inc. (IDT) is the supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacturing of custom DNA and RNA oligonucleotides (oligos) for research applications.IDT's mission is to enable discovery in biology and medicine. The company strives to achieve this by improving nucleic acid synthesis technology and developing new applications for the use of DNA- and RNA-based compounds. </p1> | <p1> Integrated DNA Technologies, Inc. (IDT) is the supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacturing of custom DNA and RNA oligonucleotides (oligos) for research applications.IDT's mission is to enable discovery in biology and medicine. The company strives to achieve this by improving nucleic acid synthesis technology and developing new applications for the use of DNA- and RNA-based compounds. </p1> | ||
</div> | </div> | ||
+ | </div> | ||
− | + | <div class="col-container"> | |
<div class="col"> | <div class="col"> | ||
− | + | ||
<img src="https://static.igem.org/mediawiki/2018/c/c0/T--Imperial_College--biolabs.png"width="20%"> | <img src="https://static.igem.org/mediawiki/2018/c/c0/T--Imperial_College--biolabs.png"width="20%"> | ||
Line 91: | Line 102: | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
<div class="col"> | <div class="col"> | ||
− | + | ||
</br> | </br> | ||
<img src="https://static.igem.org/mediawiki/2018/2/26/T--Imperial_College--SnapGene_Logo_%28White%29_576.png"width="20%"> | <img src="https://static.igem.org/mediawiki/2018/2/26/T--Imperial_College--SnapGene_Logo_%28White%29_576.png"width="20%"> | ||
Line 103: | Line 111: | ||
</div> | </div> | ||
− | + | </div> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
Latest revision as of 06:40, 17 October 2018
Sponsors